MetaADEDB 2.0 @ LMMD
Creatine
(CVSVTCORWBXHQV-UHFFFAOYSA-N)
Structure
SMILES
OC(=O)CN(C(=N)N)C
Type(s)
Approved; Investigational; Nutraceutical
Molecular Formula:
C4H9N3O2
Molecular Weight:
131.133
Log P:
-0.3037
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
3
TPSA:
90.41
CAS Number(s):
57-00-1
Synonym(s)
1.
Creatine
External Link(s)
MeSHD003401
PubChem Compound586
BindingDB50357229
ChEBI16919
CHEMBLCHEMBL283800
DrugBankDB00148
DrugCentral4661
IUPHAR/BPS Guide to PHARMACOLOGY4496
KEGGcpd:C00300
Therapeutic Target DatabaseD01WZG
ZINC3861770
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Acidosis, Lactic20223410CTD
2Acute kidney injury

View details

12394880
16509464
20223410
22005293
 		CTD
3Arthritis, Experimental24709313CTD
4Atrial Fibrillation15899738CTD
5Autistic Disorder16818868CTD
6Bipolar Disorder17988366CTD
7Blood creatine increasedCanada Vigilance: 1Canada Vigilance
8Chemical and Drug Induced Liver Injury18452122CTD
9Chest PainCanada Vigilance: 1Canada Vigilance
10Cholestasis18452122CTD
11Cocaine-Related Disorders19906515CTD
12Compartment syndromes10764196CTD
13Creatine deficiency, X-linked12210795CTD
14Dehydration10075534CTD
15Depressive disorder9018096
17988366		CTD
16Diarrhea11740307
15795816		CTD
17Dyskinesia, Drug-Induced18762218CTD
18Edema15795816CTD
19Erectile dysfunctionCanada Vigilance: 1Canada Vigilance
20ErythemaCanada Vigilance: 1Canada Vigilance
21Glomerulonephritis, Membranoproliferative14725210CTD
22Heat Stroke12182766CTD
23Huntington Disease19476553CTD
24HypersensitivityCanada Vigilance: 1Canada Vigilance
25Kidney Diseases20061359CTD
26Muscle Cramp11740307CTD
27Muscular Atrophy17053101CTD
28Nausea10075534
15795816		CTD
29Nephritis, Interstitial10075534CTD
30Pain10075534CTD
31Parkinsonian Disorders19476553CTD
32Postoperative Complications16509464CTD
33PruritusCanada Vigilance: 1Canada Vigilance
34Psychoses, Substance-Induced20433105CTD
35Pulmonary Edema12394880CTD
36Respiratory Insufficiency12394880CTD
37Rhabdomyolysis10764196
12394880
16509464		CTD
38Sprains and Strains11740307CTD
39SwellingCanada Vigilance: 1Canada Vigilance
40ThrombosisCanada Vigilance: 1Canada Vigilance
41Vomiting10075534CTD
42jaundice18452122CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.